| Biomarker ID | 1534 |
| PMID | 25190021 |
| Year | 2014 |
| Biomarker | miRNA-21 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa( BPH: 1.3 ± 3.6; PCa:4.5 ± 3.6) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathway include: MicroRNAs in cancer; cellular protein modification process; protein modification process; protein binding; negative regulation of cellular metabolic process |
| Experiment | Prostata Cancer Vs Benign prostatic hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | 20 patients were enrolled in the study. 10 of them had Prostate Cancer and 10 had Benign prostatic hyperplasia (BPH) |
| Senstivity | 90% |
| Specificity | 90% |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.003 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |